1,375
Views
31
CrossRef citations to date
0
Altmetric
Reviews

Medical marijuana in neurology

, , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Neta HaGani, Sharon Sznitman, Michael Dor, Gil Bar-Sela, Dana Oren, Lilia Margolis-Dorfman, Itay Goor-Aryeh & Manfred S Green. (2022) Attitudes Toward the Use of Medical Cannabis and the Perceived Efficacy, Side-effects and Risks: A Survey of Patients, Nurses and Physicians. Journal of Psychoactive Drugs 54:5, pages 393-402.
Read now
Nichole Stetten, Jamie Pomeranz, Michael Moorhouse, Ali Yurasek & Amy V. Blue. (2020) The level of evidence of medical marijuana use for treating disabilities: a scoping review. Disability and Rehabilitation 42:9, pages 1190-1201.
Read now

Articles from other publishers (29)

Ofira Zloto, Alon Weisman, Inbal Avisar, Tal Serlin, Lihi Bar-lev, Ayelet Priel, Daphna Landau Prat, Nira Granot, Iris Weisman & Guy Ben Simon. (2022) Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study. Graefe's Archive for Clinical and Experimental Ophthalmology 260:5, pages 1707-1712.
Crossref
Sindhu Ramesh, Kruthi Gopal, Jack Deruiter, Payton Lowery, Manoj Govindarajulu, Suhrud Pathak, Rishi Nadar, Dinesh Chandra Agrawal & Muralikrishnan Dhanasekaran. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare 155 172 .
Dylan Bowen, Sindhu Ramesh, Jack Deruiter, Manoj Govindarajulu, Payton Lowery, Timothy Moore, Dinesh Chandra Agrawal & Muralikrishnan Dhanasekaran. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare 35 52 .
Wilfrid Beneche, Lisa Cain & Andrew Moreo. (2023) A High Wire Act: Balancing Guest, Employee, and Organizational Perspectives concerning Marijuana Use in the Hospitality Industry. Journal of Hospitality & Tourism Cases 9:4, pages 6-11.
Crossref
Susan J. Thanabalasingam, Brandan Ranjith, Robyn Jackson & Don Thiwanka Wijeratne. (2021) Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis. Therapeutic Advances in Neurological Disorders 14, pages 175628642110185.
Crossref
Genís Oña & José Carlos Bouso. (2020) Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology. Current Medicinal Chemistry 28:1, pages 53-68.
Crossref
Stefan Dhein. (2020) Different Effects of Cannabis Abuse on Adolescent and Adult Brain. Pharmacology 105:11-12, pages 609-617.
Crossref
Tyler E. Gaston, Jerzy P. Szaflarski, Allen C. Bowling, Ying Liu, Tristan Seawalt, Maureen A. Leehey, E. Lee Nelson, Sharad Rajpal, Alan T. Villavicencio, Andrew Bauer & Sigita Burneikiene. 2020. Cannabis in Medicine. Cannabis in Medicine 231 312 .
Adeyinka Charles AdejumoRyan FlanaganBraden KuoKyle Staller. (2019) Relationship Between Recreational Marijuana Use and Bowel Function in a Nationwide Cohort Study. American Journal of Gastroenterology 114:12, pages 1894-1903.
Crossref
Arum KimChristopher N. KaufmannRoxanne KoZujun LiBenjamin H. Han. (2019) Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State. Journal of Palliative Medicine 22:10, pages 1196-1201.
Crossref
José Alexandre S. Crippa, Jaime E. C. Hallak, Antônio W. Zuardi, Francisco S. Guimarães, Vitor Tumas & Rafael G. dos Santos. (2019) Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?. European Archives of Psychiatry and Clinical Neuroscience 269:1, pages 121-133.
Crossref
Nancy Maurya & Bharath Kumar Velmurugan. (2018) Therapeutic applications of cannabinoids. Chemico-Biological Interactions 293, pages 77-88.
Crossref
Emilio Perucca. (2017) Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?. Journal of Epilepsy Research 7:2, pages 61-76.
Crossref
James A. Cranford, J. Todd Arnedt, Deirdre A. Conroy, Kipling M. Bohnert, Carrie Bourque, Frederic C. Blow & Mark Ilgen. (2017) Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain. Drug and Alcohol Dependence 180, pages 227-233.
Crossref
Samir K. Ballas. (2017) The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises. Cannabis and Cannabinoid Research 2:1, pages 197-201.
Crossref
Hélio A. G. Teive, Francisco M.B. Germiniani, Pedro A. Kowacs & Renato P. Munhoz. (2016) Charcot, Mitchell and Lees: neurology free thinkers and their experiences of psychoactive drugs. Arquivos de Neuro-Psiquiatria 74:12, pages 1035-1038.
Crossref
Pichet Termsarasab, Thananan Thammongkolchai & Steven J. Frucht. (2016) Medical treatment of dystonia. Journal of Clinical Movement Disorders 3:1.
Crossref
David Z. Rose. (2016) What a downer: The dark side of cannabis. Journal of the Neurological Sciences 364, pages 189-190.
Crossref
Jonathan Rabner, Sarah Gottlieb, Lori Lazdowsky & Alyssa LeBel. (2016) Psychosis following traumatic brain injury and cannabis use in late adolescence. The American Journal on Addictions 25:2, pages 91-93.
Crossref
Cecilia Zavala-Tecuapetla & Luisa Rocha. 2016. Antiepileptic Drug Discovery. Antiepileptic Drug Discovery 83 96 .
Jane Sachs, Erin McGlade & Deborah Yurgelun-Todd. (2015) Safety and Toxicology of Cannabinoids. Neurotherapeutics 12:4, pages 735-746.
Crossref
Barbara S. Koppel. (2015) Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics. Neurotherapeutics 12:4, pages 788-792.
Crossref
Magdalena Taschwer & Martin G. Schmid. (2015) Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability. Forensic Science International 254, pages 167-171.
Crossref
Briony Catlow & Juan Sanchez-Ramos. (2015) Cannabinoids for the Treatment of Movement Disorders. Current Treatment Options in Neurology 17:9.
Crossref
Juan Sanchez‐Ramos. (2015) The entourage effect of the phytocannabinoids. Annals of Neurology 77:6, pages 1083-1083.
Crossref
Clifford B. Saper. (2015) Reply to Letter. Annals of Neurology 77:6, pages 1083-1084.
Crossref
Donald E. Greydanus, Gabriel Kaplan, Louis E. BaxterSrSr, Dilip R. Patel & Cynthia L. Feucht. (2015) Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?. Disease-a-Month 61:4, pages 118-175.
Crossref
Melvyn Weibin Zhang & Roger C. M. Ho. (2015) The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy. Journal of Addiction 2015, pages 1-6.
Crossref
István Katona. 2015. Endocannabinoids. Endocannabinoids 285 316 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.